RBMY1A1 and hepatocellular carcinoma: The present study aimed to evaluate the transformation and anti-apoptotic efficacy of RBMY in human hepatoma cells, and the hepatocarcinogenic efficacy of RBMY in transgenic mice, and to explore its possible underlying molecular mechanisms.